Research Updates

Government announces major prostate cancer screening trial to end needless prostate deaths

Government announces major prostate cancer screening trial to end needless prostate deaths
Research Updates

Pluvicto™ Update

Pluvicto™ Update
Research Updates

Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland

Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
Research Updates

Exploring men’s psychological adjustment to prostate cancer

Exploring men’s psychological adjustment to prostate cancer
Research Updates

NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer

NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
Research Updates

#GiveMenMoreTime – NICE reopens consultation on Pluvicto

#GiveMenMoreTime – NICE reopens consultation on Pluvicto
All, PCR News, Research Updates

Predicting which cancers will return

Predicting which cancers will return
Research Updates

TOPiC: Talking with men about treatment Options for Prostatic Cancer

TOPiC: Talking with men about treatment Options for Prostatic Cancer
PCR News, Research Updates

Unlocking Prostate Cancer Data

Unlocking Prostate Cancer Data
Research Updates

NICE consults on provisional decision to block NHS access to Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) radioligand therapy for advanced prostate cancer

NICE consults on provisional decision to block NHS access to Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) radioligand therapy for advanced prostate cancer
Research Updates

Thousands of men likely to benefit from new drug which extends life

Thousands of men likely to benefit from new drug which extends life
Research Updates

Government commits £260 million to boost NHS-led research

Government commits £260 million to boost NHS-led research
Load more
Press enter or esc to cancel